Mediterranean Diet and Patients With Psoriasis
JAMA Dermatology · 01.12.2025 · 161 (12) · 1215
DOI: 10.1001/jamadermatol.2025.3410 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JAMA Dermatology, erschienen am 01.12.2025. Verfasst von Javier Perez-Bootello und 16 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario Ramón y Cajal, Department of Dermatology, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain. Hauptthemen laut MEDLINE: Diet, Mediterranean, Psoriasis. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Despite growing interest on the role of diet in the prevention and treatment of psoriasis, randomized clinical trials are lacking. The Mediterranean diet is known for its anti-inflammatory and cardiometabolic benefits, which may be relevant to psoriasis pathophysiology.
Objective
To assess whether a 16-week Mediterranean diet intervention would improve psoriasis severity in patients with mild to moderate disease. Design, Setting, and Participants MEDIPSO (Impact of the Mediterranean Diet on Patients With Psoriasis), an open-label, single-center, single-blinded (evaluator) randomized clinical trial, was conducted from February 2024 to March 2025 at a dermatology referral clinic in Madrid, Spain. Participants were adults with mild to moderate psoriasis (Psoriasis Area and Severity Index [PASI] of 2-10, with higher scores indicating maximal disease) receiving stable topical therapy.
Interventions
Participants were randomized 1:1 to the intervention or control group. The intervention group received a 16-week, dietitian-guided Mediterranean diet program, including nutritional counseling, educational materials, and weekly provision of extra virgin olive oil. The control group received standard low-fat dietary advice without dietitian supervision. Main Outcomes and Measures The primary outcome was the change in the PASI from baseline to week 16. Secondary outcomes included changes in Mediterranean diet adherence, anthropometric and metabolic parameters, serum inflammatory cytokines, and patient-reported outcomes. Estimated marginal means (EMMs) at baseline and for the change from baseline to week 16 were reported, with the intervention effect presented as the between-group difference.
Results
Among 45 individuals screened, 38 participants were enrolled and randomized (mean [SD] age, 46.4 [12.8] years; 25 males [65.8%]); 19 were randomized to the intervention group and 19 were randomized to the control group; 37 individuals (97.4%) completed the study. The EMM PASI change at week 16 was −3.4 (95% CI, −4.4 to −2.4) in the intervention group and 0.0 (95% CI, −1.0 to 1.0) in the control group; the between-group EMM difference was −3.4 (95% CI, −4.8 to −2.0; P < .001). Nine of 19 participants in the Mediterranean diet group (47.4%) achieved PASI 75 (a 75% reduction in PASI) compared with none in the control group. A significant reduction in EMM hemoglobin A 1c (glycated hemoglobin) was observed in the intervention group as compared with the control group (between-group EMM difference, −4.1 mmol/mol [95% CI, −6.9 to −1.3 mmol/mol]; P = .01). Conclusions and Relevance This randomized clinical trial found that a 16-week Mediterranean diet intervention significantly improved psoriasis severity in patients with mild to moderate disease receiving stable topical therapy. These findings suggest that incorporating dietary strategies may be beneficial as an adjunctive therapy in psoriasis management. Trial Registration ClinicalTrials.gov Identifier: NCT06257641
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hospital Universitario Ramón y Cajal, Department of Dermatology, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.
- Programa de Doctorado en Ciencias de la Salud, Alcalá de Henares University, Madrid, Spain.
- Department of Preventive Medicine and Public Health, Instituto de Investigación Sanitaria de Navarra, University of Navarra, Pamplona, Spain.
- Centro de Investigación Biomédica en Red de la Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain.
- Faculty of Medicine, Universidad Francisco de Vitoria, Medicine Faculty, Madrid, Spain.
- Blauvelt Consulting, LLC, Annapolis, Maryland.
Zitieren
APA
Perez-Bootello, J., Berna-Rico, E., Abbad-Jaime de Aragon, C., Goni, L., Vazquez-Ruiz, Z., Neria, F., Cova-Martin, R., Naharro-Rodriguez, J., Ballester-Martinez, A., Pindado-Ortega, C., Monge, D., Blauvelt, A., Jaen, P., Mehta, N., Gelfand, J. M., Martinez-Gonzalez, M. A., & Gonzalez-Cantero, Á. (2025). Mediterranean Diet and Patients With Psoriasis. JAMA Dermatology, 161(12), 1215. https://doi.org/10.1001/jamadermatol.2025.3410
Vancouver
Perez-Bootello J, Berna-Rico E, Abbad-Jaime de Aragon C, Goni L, Vazquez-Ruiz Z, Neria F, et al. Mediterranean Diet and Patients With Psoriasis. JAMA Dermatology. 2025;161(12):1215. doi:10.1001/jamadermatol.2025.3410
BibTeX
@article{PerezBootello2025,
author = {Perez-Bootello, Javier and Berna-Rico, Emilio and Abbad-Jaime de Aragon, Carlota and Goni, Leticia and Vazquez-Ruiz, Zenaida and Neria, Fernando and Cova-Martin, Ruth and Naharro-Rodriguez, Jorge and Ballester-Martinez, Asuncion and Pindado-Ortega, Cristina and Monge, Diana and Blauvelt, Andrew and Jaen, Pedro and Mehta, Nehal and Gelfand, Joel M and Martinez-Gonzalez, Miguel A and Gonzalez-Cantero, Álvaro},
title = {Mediterranean Diet and Patients With Psoriasis},
journal = {JAMA Dermatology},
year = {2025},
volume = {161},
number = {12},
pages = {1215},
doi = {10.1001/jamadermatol.2025.3410}
}
EUVIMED